Novorex

Novorexovorex is a company specializing in the development of novel small-molecule drugs, primarily targeting oncology and neurology diseases. It aims to develop new drugs, including undruggable targets, by combining biophysical analysis with in vitro/in vivo assays in drug design, while accelerating the drug discovery process and reducing the time costs associated with traditional high-throughput screening (HTS) methods.